Devices and genomic therapies

Alana Kurtti; Jared Jagdeo

doi:10.1016/B978-0-323-82921-2.00026-3

Devices and genomic therapies

Alana Kurtti
, Jared Jagdeo

Dermatology

SUNY Downstate Health Sciences University

Englewood Health

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

There is an unmet medical need for tolerable and effective androgenetic alopecia therapies. Emerging treatments include CRISPR-Cas9 (clustered, regularly interspaced, short palindromic repeats-CRISPR associated protein 9) gene editing, small interfering RNA (siRNA), microRNA (miRNA), and tissue engineering. However, extensive research investigating the safety and efficacy of these modalities is required before they can be employed in human studies.

Original language	English
Title of host publication	Procedures in Cosmetic Dermatology
Subtitle of host publication	Hair Restoration
Publisher	Elsevier
Pages	207-218
Number of pages	12
ISBN (Electronic)	9780323829212
ISBN (Print)	9780323829229
DOIs	https://doi.org/10.1016/B978-0-323-82921-2.00026-3
State	Published - Jan 1 2023

Keywords

Androgenetic alopecia
CRISPR
CRISPR-Cas9
RNA
devices
emerging
gene therapy
genomic therapies
miRNA
siRNA
therapies
tissue engineering

Access to Document

10.1016/B978-0-323-82921-2.00026-3

Cite this

@inbook{d9534c33b7d64b21889dd3aab5c2ad9a,

title = "Devices and genomic therapies",

abstract = "There is an unmet medical need for tolerable and effective androgenetic alopecia therapies. Emerging treatments include CRISPR-Cas9 (clustered, regularly interspaced, short palindromic repeats-CRISPR associated protein 9) gene editing, small interfering RNA (siRNA), microRNA (miRNA), and tissue engineering. However, extensive research investigating the safety and efficacy of these modalities is required before they can be employed in human studies.",

keywords = "Androgenetic alopecia, CRISPR, CRISPR-Cas9, RNA, devices, emerging, gene therapy, genomic therapies, miRNA, siRNA, therapies, tissue engineering",

author = "Alana Kurtti and Jared Jagdeo",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-82921-2.00026-3",

language = "English",

isbn = "9780323829229",

pages = "207--218",

booktitle = "Procedures in Cosmetic Dermatology",

publisher = "Elsevier",

}

TY - CHAP

T1 - Devices and genomic therapies

AU - Kurtti, Alana

AU - Jagdeo, Jared

PY - 2023/1/1

Y1 - 2023/1/1

N2 - There is an unmet medical need for tolerable and effective androgenetic alopecia therapies. Emerging treatments include CRISPR-Cas9 (clustered, regularly interspaced, short palindromic repeats-CRISPR associated protein 9) gene editing, small interfering RNA (siRNA), microRNA (miRNA), and tissue engineering. However, extensive research investigating the safety and efficacy of these modalities is required before they can be employed in human studies.

AB - There is an unmet medical need for tolerable and effective androgenetic alopecia therapies. Emerging treatments include CRISPR-Cas9 (clustered, regularly interspaced, short palindromic repeats-CRISPR associated protein 9) gene editing, small interfering RNA (siRNA), microRNA (miRNA), and tissue engineering. However, extensive research investigating the safety and efficacy of these modalities is required before they can be employed in human studies.

KW - Androgenetic alopecia

KW - CRISPR

KW - CRISPR-Cas9

KW - RNA

KW - devices

KW - emerging

KW - gene therapy

KW - genomic therapies

KW - miRNA

KW - siRNA

KW - therapies

KW - tissue engineering

UR - https://www.scopus.com/pages/publications/85160130682

U2 - 10.1016/B978-0-323-82921-2.00026-3

DO - 10.1016/B978-0-323-82921-2.00026-3

M3 - Chapter

SN - 9780323829229

SP - 207

EP - 218

BT - Procedures in Cosmetic Dermatology

PB - Elsevier

ER -

Devices and genomic therapies

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this